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Abstract.  Herbimycin A  is one of the benzenoid an- 
samycin antibiotics isolated from a  culture of a Strep- 
tomyces  species (Omura,  S., A.  Nakagawa, and N. 
Sadakane.  1979.  Tetrahedron  Lett.  1979:  4323-4326). 
Recent studies have shown that the antibiotic not only 
inhibits the phosphorylation of p60  src in Rous sarcoma 
virus- (RSV)  infected cells, but also reverses the cel- 
lular phenotypes acquired by transfection with tyrosine 
kinase oncogenes (Uehara,  Y.,  M.  Hori, T.  Takeuchi, 
and H.  Umezawa.  1985.  Jpn.  J.  Cancer Res.  76:672- 
675;  Uehara,  Y.,  M.  Hori, T.  Takeuchi, and H. 
Umezawa.  1986.  Mol.  Cell.  Biol.  6:  2198-2206;  Ue- 
hara,  Y.,  Y.  Murakami, S.  Mizuno, and S.  Kawai. 
1988.  Virology.  164:  294-298).  These studies and 
other evidence indicate that the antibiotic inhibits a 
reaction(s) closely associated with the function of cel- 
lular tyrosine kinases. 
We have found that herbimycin A  is an effective in- 
ducing agent capable of triggering differentiation in 
two typical mouse in vitro differentiation systems, 
which have been considered to be quite different in 
their mechanism of induction: endoderm differentiation 
of embryonal carcinoma (F9) cells and terminal 
erythroid differentiation of erythroleukemia (MEL) 
cells. The results suggest that there is a  common step 
in the intracellular differentiation cascade which is, 
directly or indirectly, associated with phosphorylation 
at specific (tyrosine) residues of cellular proteins.  The 
significance of this finding with respect to the molecu- 
lar mechanism of in vitro differentiation is discussed. 
T 
HERE are a number of agents that trigger in vitro dif- 
ferentiation in established mammalian cell lines. Since 
the morphological and biochemical changes induced 
by such inducing agents are often quite analogous to those 
observed  in  vivo,  in  vitro  differentiation has  been  used 
widely as a  model to  study the  molecular mechanism of 
differentiation. One of the interesting but puzzling problems 
of in vitro differentiation is that compounds which are struc- 
turally  and  presumably  functionally  unrelated  are  often 
equally effective in inducing a  specific differentiation. For 
example, more than a dozen compounds with a wide spec- 
trum of structures ranging from a simple compound such as 
dimethyl sulfoxide (DMSO)  (Friend et al.,  1971) to more 
complex proteins like proteases (Scher et al.,  1982) induce 
the differentiation of mouse erythroleukemia (MEL) cells 
(Friend et al., 1966; Marks and Rifkind, 1989) to erythroid 
cells. One possible explanation is that the intracellular mo- 
lecular cascades leading to differentiation are quite diver- 
sified at the initial stage, but eventually converge to a single 
critical step (or reaction), although it may be naive to believe 
that such a step exists universally among all or most differen- 
tiation processes. 
Herbimycin A is one of the benzenoid ansamycin antibiot- 
ics isolated from a culture of a Streptomyces species (Omura 
et al., 1979; Uehara et al., 1985). The antibiotic was shown 
to reduce the phosphorylation of p60 ~rc in a rat kidney cell 
line infected with Rous sarcoma virus (RSV) (Uehara et al., 
1986).  Tyrosine kinase activity associated with p60  src in the 
antibiotic-treated cell extracts was found to be inactivated. 
Furthermore,  herbimycin  A  reversed  the  morphological 
changes  in chicken and  mammalian cells  transformed by 
tyrosine kinase oncogenes such as src, yes, fps, ros, abl, and 
erbB, but had no effect on the changes induced by nontyro- 
sine kinase oncogenes such as ras, raf, or myc (Uehara et al., 
1988; Murakami et al., 1988). These results strongly suggest 
that herbimycin A inhibits, or interferes with, a reaction(s) 
closely associated with the maintenance of functional in- 
tegrity of tyrosine kinase in the cells. 
To obtain a clue to the possible common reaction underly- 
ing a variety of types of in vitro differentiation, we examined 
the effect of herbimycin A on two typical in vitro mouse cell 
differentiation systems. One is that of embryonal carcinoma 
(F9)  cells  (Bernstein  et  al.,  1973),  which  show  retinoic 
acid-induced differentiation into endoderm cells (Strickland 
and  Mahdavi,  1978) and  the  other  is  that of MEL cells 
(Friend et al., 1966), which undergo terminal differentiation 
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1971) or hexamethylenebisacetamide (HMBA) t (Reuben et 
al., 1976). We report here that herbimycin A is an effective 
inducing agent which triggers differentiation of both F9 and 
MEL cells. We also discuss the biological significance of the 
results with respect to the possible involvement of protein 
phosphorylation (or dephosphorylation) as a common and 
critical factor in in vitro differentiation. 
Materials and Methods 
Materials 
Herbimycin A was isolated as described previously (Uehara et al.,  1985). 
Retinoic acid and dibutyryl cyclic AMP were purchased from Sigma Chem- 
ical Co. (St. Louis, MO), human plasminogen was from Green Cross Co. 
(Osaka,  Japan),  FITC-conjugated  goat anti-rabbit IgG  and  rabbit anti- 
mouse IgG were from Cappel Laboratories (Malvern, PA) and skim milk, 
gelatin, and agar noble were from Difco Laboratories Inc. (Detroit, MI). 
HMBA and PMA (phorbol 12-myristate 13-acetate) were gifts from T. Ya- 
mane (Bell Laboratories, Murray Hill, N J) and M. Terada (National Cancer 
Institute, Tokyo), respectively. Anti-laminin antibody was purchased from 
Bioscience  Products  AG  (Emmenbrticke,  Switzerland).  Anti-stage-spe- 
cific embryonic antigen-1 (SSEA-1) was provided by D. Solter (Wistar Insti- 
tute,  Philadelphia,  PA)  through  T.  Muramatsu  (Kagoshima  University, 
Kagoshima, Japan). All other agents were reagent grade. MEM, DME, and 
ES medium (MEM supplemented with L-asparagine, L-aspartic acid, L-ala- 
nine, L-glutamic acid, glycine,  L-proline,  L-serine, sodium pyruvate,  and 
cyanocobalamin) were purchased from Nissui Seiyaku (Tokyo).  FCS was 
obtained from Sigma Chemical Co.  (St.  Louis, MO). 
Cells and Cell Culture 
F9 cells were supplied by Y.  Nishimune (Institute of Microbial Diseases, 
Osaka University, Osaka) and MEL (Friend) cells (745A, DSI9) by M. Ter- 
ada (National Cancer Center Institute, Tokyo). b9 and MEL cells were cul- 
tured at 37°C in a CO2 (5%) incubator in ES medium supplemented with 
FCS (10% [vol/vol]) and MEM with FCS (12% [vol/vol]), respectively. For 
F9 cells, plastic tissue culture dishes (Falcon Labware, Oxnard, CA) were 
coated with gelatin solution (0.4%  [wt/vol]) before use. In the case of the 
medium used for assaying the colony-forming ability of MEL cells, DME 
was  supplemented  with FCS  (15%  [vol/vol]) and methylcellulose (1.5% 
[wt/voll). 
Assays for Plasminogen Activator (F9 Cells), SSEA4 
(F9 Cells), Laminin (F9 Cells), and Hemoglobin 
(MEL Cells) 
Plasminogen activator was assayed as described by Nishimune et al. (1983). 
In essence,  F9 cells, grown in ES with FCS (10%  [vol/vol]) on gelatin- 
coated plastic Petri dishes (Falcon Labware), were overlayed with the ES 
medium containing agar noble (0.75 % [wt/vol]), skim milk (2.5 % [wt/vol]), 
and human plasminogen (0.2 casein U/ml). After 24 h of incubation at 37°C 
in a CO2 incubator, the haloes developed were counted.  Usually over 200 
colonies per plate (in duplicate) were examined. 
Laminin was detected by staining the cells with antibody against laminin. 
For this, F9 cells grown on plastic Petri dishes (35 mm diam) were fixed 
with methanol-acetic acid mixture (20:1) (15 min at room temperature) and 
washed with 0.05%  (vol/vol) Tween 20 (Wako Junyaku,  Tokyo)  in PBS. 
Anti-laminin antibody (100/zl, diluted 100-fold from the original sample) 
was then added to the dish and left for 1 h at 37°C.  After washing twice 
with the Tween solution,  FITC-conjugated goat anti-rabbit IgG (100 /~1, 
diluted 500-fold from the original sample) was added and the samples were 
left at 37°C for I h. They were then washed with the Tween solution, and 
after addition of one drop of Na2CO3-NaHCO3  (0.05  M) buffer (pH 9.5) 
in glycerol, photographs were taken using a Nikon Optiphot epifluorescence 
microscope with a B-2 filter equipped with a Microflex UFX-II photomicro- 
graphic attachment. 
1. Abbreviations used in this paper: HMBA, hexamethylenebisacetamide; 
PMA, phorbol  12-myristate  13-acetate; SSEA-1,  stage-specific embryonic 
antigen-1. 
SSEA-I  was detected in the same way as for laminin (described above) 
except that anti-SSEA-1 antibody (diluted 1,000-fold)  and FITC-conjugated 
rabbit anti-mouse IgG (diluted 200-fold) were used instead of anti-laminin 
antibody and FITC-conjugated goat anti-rabbit IgG, respectively. 
Hemoglobin accumulation in MEL cells was assayed according to the 
method of Orkin et al.  (1975),  staining the cells with benzidine. 
Detection of l3 Globin-specific Transcripts 
The total RNA  was extracted  from  MEL cells by the phenol procedure 
(Favaloro et al.,  1980) and was  subjected to gel electrophoresis.  The/3 
globin-specific transcripts were identified by Northern hybridization (Gold- 
berg,  1980) using 32P-labeled  (Rigby et al.,  1977) cloned mouse ~  major 
globin (pM/3G) DNA and chicken ~  actin (pAl) DNA (Tokunaga et al., 
1986) probes. These cloned DNA materials were supplied by T. Yamashita 
(Institute of Physical and Chemical Research, Saitama) (pM/~G) and by S. 
Sakiyama (Chiba Cancer Center, Chiba) (pAl). 
Assay of Colony-forming Ability of MEL Cells 
MEL cells cultured in MEM with FCS were diluted with the fresh medium 
to 2  ×  IO  s cells/ml and incubated in plastic dishes (Falcon Labware; 24 
wells, each 1.O ml) in the presence (or absence) of herbimycin A in a CO2 
incubator at 37°C. After 2 d, the cells were washed twice with PBS to re- 
move the drug. The cells were then plated on a semi-solid medium (DME 
with 15% FCS and  1.5%  methylcellulose) in plastic Petri dishes (60 mm 
diam) after appropriate dilution which gave ,',d,000 cells per dish. After in- 
cubation for 2 wk at 37°C in a CO2 incubator, the number of colonies was 
counted. 
Results 
Induction of Differentiation ofF9 Cells 
F9 ceils, an established cell line of mouse embryonal carci- 
noma cells (Bernstein et al., 1973), differentiate in vitro into 
endoderm cells upon induction by retinoic acid (Stricldand 
and Mahdavi, 1978). The presence of dibutyryl cyclic AMP 
along with retinoic acid further stimulates the differentiation, 
and the cells that differentiate under this condition exhibit 
biochemical and morphological characteristics of parietal 
endoderm cells (Stricldand and Mahdavi, 1978; Strickland 
et at.,  1980;  Hogan et al.,  1981). 
Before we  examined the  effect of herbimycin A  on F9 
differentiation, we had confirmed the inhibitory effect of her- 
bimycin A on protein phosphorylation at tyrosine residues. 
For this, F9 cells were labeled in ES medium (with limited 
phosphate) with riP-phosphate  (1  mCi/ml) in the presence 
of different concentrations of herbimycin A  and  the  im- 
munoprecipitates  with  phosphotyrosine  specific  antibody 
(Ohtsuka et al.,  1984) from the cell extracts were analyzed 
by  autoradiography  and  densitometry  after  SDS-PAGE. 
Consistent with the previous finding (Uehara et al.,  1986), 
incorporation of riP-phosphate  into proteins  reacted  with 
the antibody was uniformly reduced by >98% at 0.5 #g/ml 
of herbimycin A concentration when incorporation into the 
total protein was reduced by 25.5%  (data not shown). 
When F9 cells were incubated with herbimycin A  (0.5 
/~g/ml) for 4 d, the drug induced changes in the morphology 
of the cells (Fig. 1 D). Since the changes were quite similar 
to those induced by retinoic acid plus dibutyryl cyclic AMP 
(Fig. 1 C), the antibiotic seemed to have triggered differenti- 
ation of F9 cells into endoderm-like cells (Strickland et al., 
1981; Hogan et al., 1981). The morphological changes were 
irreversible because the cells still maintained their changed 
morphology even after removal of the drug (data not shown). 
To confirm the effect of herbimycin A  on F9 cells,  we 
treated the cells with the antibiotic for 2 d and overlaid them 
The Journal of Cell Biology, Volume 109,  1989  286 Figure 1.  Changes in morphology of herbimycin A-treated F9 cells. F9 cells (,'~105 cells per dish) were plated on gelatin-coated Petri 
dishes (Falcon Labware; 60 mm diam). Retinoic acid (1/zM) and retinoic acid (1 tzM) plus dibutyryl cyclic AMP (1 mM) or herbimycin 
A (0.5/~g/ml) was then added and, after 4 d incubation in a CO2 incubator at 37°C,  pictures were taken using a microscope (Olympus 
IMT-2). A, control; B, retinoic acid; C, retinoic acid plus dibutyryl  cyclic AMP; and D, herbimycin A-treated cells, respectively. All pictures 
were taken at the same magnification. Bar, 0.1  mm. 
Figure 2. Induction of plasminogen acti- 
vator by herbimycin A. F9 cells (,'~2  x 
102 cells per dish) were plated on gela- 
tin-coated plastic Petri  dishes  (Falcon 
Labware; 35  mm diam) and  incubated 
for  2  d  in  a  CO2  incubator  at  37°C. 
Herbimycin A (0.5 ttg/ml) was then add- 
ed and the cells incubated for a further 
2 d. The cells were then overlaid with a 
solution containing skim milk and plas- 
minogen  (see Materials and  Methods) 
and photographs were taken 24 h later. 
A,  control  cells;  and  B,  herbimycin 
A-treated ceils. 
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Figure 3. Induction of plasminogen activator by herbimycin A in F9 
cells as a function of the drug concentration (A) and of time of incu- 
bation (B). (A) Induction as a function of herbimycin A concentra- 
tion.  F9 cells ('~2  x  102 cells per dish) were plated on gelatin- 
coated plastic  Petri dishes  (Falcon  Labware;  35  mm diam)  and 
incubated for 2 d in a CO2 incubator at 37°C. Herbimycin A at 
different concentrations as shown in the figure was then added and 
incubation of the cells was continued for 2 more days. The cells 
were then overlaid with a solution containing skim milk and plas- 
minogen (see Materials and Methods) and the number of haloes was 
counted 24 h later. The average number of haloes per dish was con- 
verted to the percentage of plasminogen activator-producing  colo- 
nies (PA  ÷ colonies) calculated from the total number of colonies. 
The percentage of PA  ÷ colonies induced by retinoic acid (1 t~M) 
was 53% under the same conditions.  (B) Induction as a function 
of incubation time. F9 cells were plated and incubated for 2 d as 
described above in A. Herbimycin A (0.5 tzg/ml) was then added 
and incubation of the cells was continued. Every day (0-5 d) after 
addition of the drug, samples were subjected to the assay of plas- 
minogen  activator  production  described  above.  The  percentage 
of PA  ÷ colonies induced by retinoic  acid (1  /xM) at the fifth day 
was 86%. 
with a medium containing skim milk and plasminogen to as- 
say the production of plasminogen activator, an indicator of 
endodermal differentiation of F9 cells (Strickland and Mah- 
davi, 1978;  Strickland et al.,  1981). A considerable number 
of haloes emerged after the herbimycin treatment (Fig. 2). 
Fig.  3 A, shows the appearance of the haloes as a function 
of herbimycin A concentration during the first 2 d of treat- 
ment.  At 0.50/zg/ml  (0.87  #M)  or higher concentrations, 
>75 % of the colonies produced plasminogen activator. The 
induction  level  was  almost equivalent  to  that  attained  by 
retinoic acid treatment (~-60-80%, at 1/~M/ml). The opti- 
mum concentration (0.87 #M) of the drug for induction was 
in the same range as that of retinoic acid (0.5-1.0 ~M). 
Fig. 3 B shows the kinetics of the appearance of the haloes 
as a function of time (days) of incubation with herbimycin 
A (0.5 #g/ml). After 2 d of incubation, close to 100% of the 
colonies had a  halo around them.  Under the same condi- 
tions,  retinoic  acid  induced  plasminogen  activator among 
'~86% of the cells (data not shown). No effect of dibutyryl 
cyclic  AMP  was  observed  on  the  herbimycin  A-induced 
differentiation (data not shown). 
To  further  confirm  the  effect  of herbimycin  A  on  F9 
differentiation, we examined the appearance of laminin using 
antibody  against  laminin.  Laminin  is  one  of the  markers 
specific to endoderm differentiation of F9 cells induced by 
retinoic acid (Knowles et al., 1980; Moore et al., 1986). As 
seen in Fig. 4, herbimycin A induced the expression of lami- 
nin in the cells to the level ever higher than that induced by 
retinoic acid (plus dibutyryc cyclic AMP). The induction of 
laminin was further confirmed by SDS-PAGE electrophoresis 
of the immunoprecipitates of proteins labeled with [35S]me- 
thionine after herbimycin A  treatment (data not shown). 
The induction  of differentiation by herbimycin A  in  F9 
cells was also confirmed by assaying the disappearance of an 
antigen specific to embryonal cells. We monitored the stage- 
specific embryonic antigen-1 (SSEA-I) during the incubation 
of F9  cells after herbimycin A  treatment.  The antigen  is 
specifically present in embryonal cells and disappears in the 
process of in vitro differentiation induced by retinoic acid 
(Solter and Knowles,  1978;  Moore et al.,  1986).  As shown 
in Fig. 5, SSEA-1, detected by FITC-labeled antibody, disap- 
peared after incubation of the cells with herbimycin A  for 
5 d. This indicates that the F9 cells lost the antigen specific 
to the embryo as they underwent  morphological and bio- 
chemical alterations in response to herbimycin A. 
These results indicate that herbimycin A induces morpho- 
logical and biochemical changes in F9 cells which are at least 
ostensibly similar to, though may not be identical with, those 
exhibited in the retinoic acid-induced differentiation. 
Induction of Terminal Differentiation of MEL Cells 
MEL  cells  (Friend  et al.,  1966),  which  normally exhibit 
characteristics of proerythroblast cells, undergo biochemical 
and morphological changes in response to inducing agents 
such as DMSO (Friend et al.,  1971) or HMBA (Reuben et 
al.,  1976).  The major changes include accumulation of he- 
moglobin (Friend et al.,  1971) and loss of proliferation ca- 
pacity (Gusella et al.,  1976;  Fibach et al.,  1977),  typical 
characteristics of erythroid cells. 
In Fig. 6, we show that exposure of MEL cells to herbimy- 
cin A induced intracellular accumuh/tion of hemoglobin. In 
this experiment, the MEL cells were exposed to herbimycin 
A at different concentrations for 2 d, the antibiotic removed, 
and the cells incubated for a further 3 d; the cells which had 
accumulated hemoglobin were assayed by benzidine staining 
(Orkin et al.,  1975).  As shown in the figure, ~70-80%  of 
the herbimycin A-treated cells became reactive to benzidine 
(B  ÷ cells) at a drug concentration of 0.5/~g/ml (0.87/~M). 
Higher concentrations  drastically  reduced  induction  (Fig. 
6).  Herbimycin A  apparently  induces  differentiation very 
efficiently because the optimum concentration (0.87 ttM) for 
induction was much lower (less than one-thousandth) than 
Figure 4. Irnmunofluorescence staining of laminin in F9 cells. F9 cells were incubated in the absence or presence of retinoic acid (1 ~M) 
plus dibutyryl cyclic AMP (1 mM) or herbimycin A (0.5 #g/ml). After 5 d of incubation, laminin was stained with FITC-labeled antibody 
as described in Materials and Methods. The photographs were taken using a Nikon Optiphot epifluorescence microscope without (phase 
microscopy) or with (fluorescent microscopy) a B-2 filter equipped with Microflex UFX-II photomicrographic attachment. A and B, cells 
incubated without the drugs (control cells); C and D, cells incubated with retinoic acid plus dibutyryl cyclic AMP; E and F, cells incubated 
with herbimycin A. A, C, and E, phase microscopy;  B, D, and F, fluorescent microscopy. Bar, 0.1 mm. 
The Journal of Cell Biology, Volume  109,  1989  288 Kondo et al, Induction of Differentiation by Herbimycin A  289 Figure 5. Immunofluorescence staining of SSEA-1 in F9 cells. F9 cells were incubated in the absence or presence of herbimycin A (0.5 
#g/mi). After 5 d of incubation, SSEA-I was stained with FITC-iabeled antibody as described in Materials and Methods. The photographs 
were taken using a Nikon Optiphot epifluorescence microscope without (phase microscopy) or with (fluorescence microscopy) a B-2 filter 
equipped with a Microflex UFX-II photomicrographic attachment. A and B, cells incubated without herbimycin A (control cells). C and 
D, cells incubated with herbimycin A. A and C, phase microscopy; B and D, fluorescence microscopy. Bar, 0.1 mm. 
that of DMSO or HMBA, for which •280  mM (DMSO) or 
5  mM  (HMBA)  is  required  to  obtain  the  same  level  of 
erythroid induction. The continuous presence of herbimycin 
A throughout the incubation (5 d) gave essentially the same 
results (data not shown) as those shown in Fig. 6, suggesting 
that the first 2 d of exposure of MEL cells to herbimycin A 
was sufficient to induce hemoglobin at the later stage (after 
third day) of incubation. 
To examine whether the accumulation of hemoglobin by 
herbimycin A (assayed by benzidine staining) accompanies 
an increase of RNA transcripts specific to ~  giobin, RNA 
was isolated from MEL cells which had been incubated with 
herbimycin A for 3 d and, after electrophoresis, analyzed by 
Northern hybridization using a cloned ~/globin gene DNA 
probe. Fig. 7 shows that ~ globin transcripts were increased 
several-fold by  herbimycin  A  treatment  and  that  the  in- 
creased level was equivalent to that observed after DMSO 
treatment. This shows that the effect of herbimycin A occurs 
at least at the transcription level, which is similar to the effect 
induced by DMSO. 
Table I shows that the induction of hemoglobin accumula- 
tion by herbimycin A was inhibited by phorbol 12-myristate 
13-acetate  (PMA)  (Yamasaki  et  al.,  1977;  Rovera et  al., 
1977) and dexamethasone (Scher et al.,  1978;  Chen et al., 
1982),  specific  inhibitors  of MEL  cell  differentiation in- 
duced by DMSO or HMBA. In this experiment, during the 
first 2 d of incubation with herbimycin A, PMA or dexameth- 
asone was added and the effect of the inhibitors on erythroid 
differentiation was examined 3 d later after removal of her- 
bimycin A and the inhibitors. It is quite clear that PMA and 
dexamethasone also  inhibited  erythroid induction  by her- 
bimycin A, as they did for induction by DMSO and HMBA 
(Table I). These results suggest that herbimycin A-induced 
erythroid differentiation shares a common reaction(s) with 
that  in  the differentiation cascade triggered by  DMSO  or 
HMBA. An early inducible reaction sensitive to PMA was 
implicated in MEL cell differentiation by the previous cell 
and cytoplast fusion experiments (Nomura and Oishi,  1983; 
Kaneko et al.,  1984; Watanabe et al.,  1985). 
We also examined whether the accumulation of hemoglo- 
bin by herbimycin A accompanied the loss of colony-forming 
ability,  another characteristic  of MEL  cell  differentiation 
(Gusella et al.,  1976; Fibach et al.,  1977). As shown in Fig. 
8,  the appearance of B  + cells accompanied the loss of the 
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Figure 6. Erythroid differenti- 
ation  induced  by herbimycin 
A  as  a  function  of the  drug 
concentration.  Herbimycin 
A  at  different concentrations 
(shown in the figure) was add- 
ed  to cultures  of MEL cells 
(2  ×  10  ~ cells/ml)  and  after 
2 d of incubation at 37°C the 
drug was removed by repeated 
(twice)  washing with  PBS. 
The cells continued to be in- 
cubated  for another  3 d  and 
benzidine-reactive  (B  +)  cells 
were counted. For details, see 
Materials  and Methods. 
colony-forming ability  of MEL  cells,  as  observed  in  the 
differentiation induced by DMSO or HMBA. Taken together, 
the various results indicate that herbimycin A induces eryth- 
roid differentiation in MEL cells in a manner indistinguish- 
able  from  that  observed  with  typical  erythroid-inducing 
agents such as DMSO or HMBA. 
Discussion 
This paper presents experimental evidence that herbimycin 
A  induces  both differentiation of mouse embryonal carci- 
noma (F9) cells into endoderm-like cells and terminal dif- 
ferentiation of erythroleukemia (MEL) cells into erythroid 
cells. This is the first demonstration that a single agent acts 
as  a  common  inducer  for the  two differentiation  systems, 
which seemed to be quite different in their mechanism of in- 
duction. MEL cells are induced to differentiate into erythroid 
cells by a  number of compounds including  DMSO (Friend 
et  al.,  1971), HMBA  (Reuben  et  al.,  1976),  butyric  acid 
(Leder and Leder,  1975;  Takahashi et al.,  1975),  but none 
of these compounds induces F9 differentiation. In contrast, 
retinoic acid, which induces F9 cells, has no effect on MEL 
cell differentiation. 
How and why does herbimycin A effectively induce these 
two different kinds of cell, whose differentiation seems to be 
executed  by  apparently  different  molecular  mechanisms? 
One straightforward answer is that herbimycin A acts on an 
intracellular reaction (or reaction product) essential for trig- 
gering  differentiation,  which  is  common to the  endoderm 
differentiation from the embryonic (F9) cells and the termi- 
nal differentiation of MEL cells. If  this is the case, intracellu- 
lar processes or cascades leading  to the  common reaction 
would be quite diversified at the initial stage and dependent 
upon the inducing agents and the cell types, but would even- 
tually  converge to  a  single common intracellular  reaction 
which is closely related to the cellular commitment to differ- 
entiate. Alternatively, it is also possible that the induction of 
differentiation by herbimycin A  is executed through an en- 
tirely  independent  cascade  from  those  functioning  in  the 
differentiation triggered by conventional inducing agents. In 
any event, it is reasonable to conclude that there is a common 
step between F9 cells and MEL cells which is responsive to 
herbimycin A. 
Previous experimental results  strongly  suggest that  her- 
bimycin A interferes with protein phosphorylation by p60  +r+ 
and other tyrosine kinases. Herbimycin A  not only reduces 
phosphorylation by p60  ~rc  (Uehara  et al.,  1986),  but  also 
specifically reverses the phenotypic changes caused by trans- 
fection of tyrosine kinase oncogenes (Uehara et al.,  1988, 
Murakami et al., 1988). If  the site of the action of herbimycin 
A  is limited to tyrosine kinases or closely associated reac- 
tions as we now believe,  the hypothetical common step in 
differentiation is likely to be related to phosphorylation of 
tyrosine residues in cellular proteins. In this respect, it may 
be  worth  mentioning  that  ST-638,  a  recently  synthesized 
phosphotyrosine  analogue,  and  genistein,  an  antibiotic, 
which inhibit protein phosphorylating activity of tyrosine ki- 
nase in vitro (Shiraishi et al.,  1987,  Akiyama et al.,  1987), 
also  induces  erythroid  differentiation  of MEL cells under 
certain conditions  (Watanabe,  T.,  T.  Shiraishi,  H.  Sasaki, 
and M. Oishi, manuscript submitted for publication). Taken 
together, one could argue that specific inhibition of protein 
Figure 7. Increase of/3 globin-specific transcripts by herbimycin A. 
MEL cells,  cultured  to confluent  growth (2  x  106/ml) in MEM 
supplemented with  12% FCS, were diluted with fresh medium to 
a cell density of 1.5  x  lOS/ml. The culture was divided into three 
(each 12 ml) and incubation was continued in the absence of drug, 
or presence of DMSO (280 mM) or herbimycin A (0.5 #g/ml). Af- 
ter 3 d of incubation,  10-ml aliquots of the cultures were withdrawn 
and RNA (80 #g) was extracted by the phenol procedure. The RNA 
(20/~g each) was then electrophoresed  and subjected to Northern 
hybridization  using cloned  mouse B globin  DNA (pM/3GA) and 
chicken/3 actin DNA (pAl) (control)  as probes.  Lane  1, control 
cells;  lane 2,  DMSO-treated  cells;  lane 3, herbimycin A-treated 
cells, Levels of erythroid differentiation in each preparation  (after 
5 d of incubation) were 0% (control),  75% (DMSO-treated cells), 
and 75 % (herbimycin A-treated).  For details,  see Materials  and 
Methods. 
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Differentiation by Herbimycin A 
B  + cells 
Addition  Herbimycin A  DMSO  HMBA 
%  %  % 
No addition  74.5  81.2  82.5 
PMA  0.0  3.3  5.6 
Dexamethasone  1.1  1.0  4.7 
PMA (100 ng/ml) or dexamethasone (10 #M) was present for the first 2 d incu- 
bation with herbimycin A, DMSO, or HMBA as described in the legend of Fig. 
6). The concentrations of herbimycin A, DMSO, and HMBA were 0.87 #M 
(0.5 #g/ml),  280 mM,  and 5 mM,  respectively. 
phosphorylation at tyrosine residues makes the cells, directly 
or indirectly, less proliferative and more susceptible to physi- 
ological  conditions  favoring  differentiation,  although  it  is 
still possible that the induction by herbimycin A was caused 
by an as yet unidentified effect of the drug (other than the in- 
hibitory effect on protein phosphorylation)  on mammalian 
cells. 
At present, it is not clear whether differentiation triggered 
by agents which reduce phosphorylated tyrosine residues in 
cellular  proteins  is  a  phenomenon  limited  to  specific  cell 
lines as reported here,  or reflects a more universal  one in- 
volved in all or most types of in vivo differentiation.  Closer 
examination of the mechanism of inhibition of tyrosine phos- 
phorylation by herbimycin A  and  the  search  for a  protein 
dephosphorylating  activity  in  the  cytoplasmic  differentia- 
tion-inducing factors for MEL cell differentiation (Nomura 
et al., 1986; Watanabe and Oishi,  1987) are the obvious steps 
to be undertaken to answer many questions regarding the bio- 
chemical nature of differentiation cascades. 
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Okamoto for preparing the manuscript; and Drs. T. Yamashita and S. Sak- 
iyama for the DNA probes used here. We are also grateful to Drs. D. Solter 
and T. Muramatsu for kindly providing antibody  against SSEA-I  and Drs. 
Y.  Watanabe  and S.  Ihara for valuable  suggestions in obtaining  antibody 
specific  to phosphotyrosine. 
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Ioo  Figure  & Effect of herbimycin 
A on colony-forming  ability of 
MEL  ceils.  MEL  cells  cul- 
tured to confluent growth were 
50  diluted  and  incubated  in  the 
o  presence of different  concen- 
trations  of herbimycin  A  as 
shown in the legend of Fig. 6. 
After 2  d  of incubation,  the 
cells  were washed  with  PBS 
and divided into two. One part was plated on a semi-solid  medium 
after appropriate dilutions and colonies were counted after 2 wk of 
incubation at 37°C. The percentage of colony formation, compared 
to the number of colonies formed by the control cells (without her- 
bimycin A treatment)  is shown in the figure (right-hand  scale). The 
colony-forming  efficiency of  the control cells was ,x,63 %. The other 
half of the cells after the initial incubation  was incubated  in liquid 
medium as done for the experiments  shown in Fig. 1 and benzidine- 
reactive (B  ÷) cells were counted after 3 d of incubation  (left scale). 
Benzidine-reactive  (B  +) cells  (e).  Colony formation (<3). 
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